no statement of use filed
on 26 Jun 2023
Last Applicant/ Owned by
75 Hayden Avenue
Lexington
MA
02421
Serial Number
88694441 filed on 15th Nov 2019
Registration Number
N/A
Correspondent Address
Bridget H. Labutta
Panitch Schwarze Belisario & Nadel LLP
Two Commerce Square
2001 Market Street, Suite 2800
Philadelphia PA 19103
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"PHARMACEUTICALS"
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotRead More
Research and development of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; research and development of pharmaceutical preparations for the treatment of liver-based disorders; research and development of oligonucleotide compounds for targeted gene silencing; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Pharmaceutical preparations for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Oligonucleotide compounds for use in the targeted delivery of RNAi therapy; Pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of various diseases, namely, rare diseases, genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; Chemical compounds in the form of a molecular nanoparticle complex that act as a platform for the delivery of RNA-based drugs to biological cells; drug delivery agents consisting of oligonucleotide compounds that facilitate the delivery of a wide range of pharmaceutical based therapies
No 88694441
No Service Mark
No 689746.0066
No
No
No
No
No
No
No
No
The mark consists of the word "DICERNA" above the word "PHARMACEUTICALS" in stylized white letters on a blue background.
| Status Date | Action Taken |
|---|---|
| 26th Jun 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 26th Jun 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 07th Feb 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 07th Feb 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 07th Feb 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 03rd Dec 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 02th Dec 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 02th Dec 2022 | SOU EXTENSION 5 GRANTED |
| 22nd Nov 2022 | SOU TEAS EXTENSION RECEIVED |
| 22nd Nov 2022 | SOU EXTENSION 5 FILED |
